Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2006; 12(48): 7810-7814
Published online Dec 28, 2006. doi: 10.3748/wjg.v12.i48.7810
Published online Dec 28, 2006. doi: 10.3748/wjg.v12.i48.7810
Prophylaxis | n (%) |
First bleeding event1 | 79 (63) |
- Cirrhosis known before admission | 40/79 |
- Prior endoscopy | 25/40 |
- Prophylaxis before admission: | 16/25 |
Esophageal varices stage 0-1: | 0/7 |
Esophageal varices stage 2-3: | 16/18 |
• Beta-blockade | 12 |
• Ligation | 2 |
• Ligation and beta-blockade | 2 |
Recurrent bleeding | 46 (37) |
- Prophylaxis before admission: | |
• None2 | 11 (24) |
• Sclerosis | 2 (4) |
• Ligation | 4 (9) |
• Beta-blockade | 13 (28) |
• Ligation/sclerosis plus beta-blockade/nitrate derivative | 16 (35) |
- Citation: Ingrand P, Gournay J, Bernard P, Oberti F, Bernard-Chabert B, Pauwels A, Renard P, Bartoli E, Cadranel JF, Barbare JC, Ingrand I, Beauchant M, Portale TCFPLL. Management of digestive bleeding related to portal hypertension in cirrhotic patients: A French multicenter cross-sectional practice survey. World J Gastroenterol 2006; 12(48): 7810-7814
- URL: https://www.wjgnet.com/1007-9327/full/v12/i48/7810.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i48.7810